US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 1.1800
- -0.0200-1.67%
Close Apr 24 16:00 ET
18.89MMarket Cap-536P/E (TTM)
1.3000High1.1700Low30.38KVolume1.1800Open1.2000Pre Close37.36KTurnover0.23%Turnover RatioLossP/E (Static)16.01MShares10.470052wk High2.99P/B15.74MFloat Cap0.660052wk Low--Dividend TTM13.34MShs Float3600.0000Historical High--Div YieldTTM10.83%Amplitude0.6600Historical Low1.2290Avg Price1Lot Size
About Alaunos Therapeutics Company
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Company Profile
SymbolTCRT
Company NameAlaunos Therapeutics
Listing DateSep 22, 2006
Founded2003
CEOMr. Dale Curtis Hogue, Jr
MarketNASDAQ
Employees1
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressNavy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-259-1970
Websitehttp://www.ziopharm.com
Company Executives
- Name
- Position
- Salary
- Dale Curtis Hogue, Jr
- Director and Interim Chief Executive Officer
- --
- Raffaele Baffa
- Chief Medical Officer
- 1.51M
- Ferdinand Groenewald
- Vice President, Finance
- --
- Abhishek K Srivastava
- Vice President, Technical Operations
- --
- Jaime Vieser
- Independent Director
- 157.15K
- Holger Weis
- Independent Director
- 168.15K
- Robert W. Postma
- Independent Director
- 158.15K
- Dr. Robert J Hofmeister, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
